Search
Now showing items 21-30 of 65
Cannabis; epidemiological, neurobiological and psychopathological issues: an update
(2017-04-13)
Cannabis is the illicit drug with both the largest current levels of consumption and the highest reported lifetime prevalence levels in the world. Across different countries, the prevalence of cannabis use varies according ...
Substance use and misuse - Legal highs
(Centre for Pharmacy Post Graduate Education (CPPE), 2016-09-21)
This is an update to the online course on substance misuse designed for post-graduate pharmacists. The update was reviewed by Public Health England and the CPPE. It was published by the CPPE in Sep 2016. It is accessed by ...
Novel Psychoactive Substances: : the pharmacology of stimulants and hallucinogens
(2016-07-02)
There are increasing levels of concern relating to the rapidly evolving novel psychoactive substances/NPS and web markets’ scenarios. The paper aims at providing an overview of the clinical pharmacological issues related ...
NPS: Medical Consequences Associated with Their Intake
(Springer Nature, 2016-06-07)
Over the last decade, the 'traditional' drug scene has been supplemented - but not replaced - by the emergence of a range of novel psychoactive substances (NPS), which are either newly created or existing drugs, including ...
Gli Psiconauti: navigatori della mente o sperimentatori chimici?
(2016-06-01)
Recentemente, all’interno delle comunità online (forum, blog, social network), si sta diffondendo una nuova generazione di consumatori di sostanze, altamente informati ed esperti nel campo delle nuove sostanze psicoattive ...
The consequences of drug misuse on post-marketing surveillance
(2016-04-25)
Over the past decade, the ‘traditional’ drug scenario has shown significant changes because of the emergence of a range of molecules, e.g. the novel psychoactive substances (NPS), which are either already existing or newly ...
Novel psychoactive substances
(2016-03)
Methoxetamine-related deaths in the UK : an overview
(2015-07-28)
Objective: The goal of this study is to provide an update on the data given on methoxetamine (MXE)-related fatalities that occurred in 2011–2013, presented at the Second International Conference on Novel Psychoactive ...